West German Study Group
Clinical trials sponsored by West German Study Group, explained in plain language.
-
New hope for early breast cancer: targeted therapy may replace chemo
Disease control Recruiting nowThis phase 3 trial is testing whether a targeted drug called sacituzumab govitecan (Trodelvy), alone or combined with the immunotherapy pembrolizumab (Keytruda), can effectively treat low-risk triple-negative breast cancer before surgery. The study aims to see if these drugs can …
Phase: PHASE3 • Sponsor: West German Study Group • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug combo could spare chemo for some breast cancer patients
Disease control Recruiting nowThis study tests a personalized treatment plan for people with HER2-positive early breast cancer. It compares a newer drug (trastuzumab-deruxtecan) against standard chemotherapy combinations to see which works better and causes fewer side effects. About 702 participants will rece…
Phase: PHASE2 • Sponsor: West German Study Group • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC